The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study
|
---|---|
Published in |
Reproductive Biology and Endocrinology, July 2012
|
DOI | 10.1186/1477-7827-10-52 |
Pubmed ID | |
Authors |
Franco Lisi, Piero Carfagna, Mario Montanino Oliva, Rocco Rago, Rosella Lisi, Roberta Poverini, Claudio Manna, Elena Vaquero, Donatella Caserta, Valeria Raparelli, Roberto Marci, Massimo Moscarini |
Abstract |
Aim of this pilot study is to examine the effects of myo-inositol administration on ovarian response and oocytes and embryos quality in non PolyCystic Ovary Syndrome (PCOS) patients undergoing multiple follicular stimulation and in vitro insemination by conventional in vitro fertilization or by intracytoplasmic sperm injection. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Italy | 3 | 33% |
Canada | 3 | 33% |
United States | 2 | 22% |
Unknown | 1 | 11% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 67% |
Practitioners (doctors, other healthcare professionals) | 3 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 80 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 14 | 18% |
Researcher | 14 | 18% |
Student > Bachelor | 10 | 13% |
Student > Master | 8 | 10% |
Student > Postgraduate | 6 | 8% |
Other | 16 | 20% |
Unknown | 12 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 32 | 40% |
Agricultural and Biological Sciences | 8 | 10% |
Nursing and Health Professions | 7 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 9% |
Biochemistry, Genetics and Molecular Biology | 6 | 8% |
Other | 4 | 5% |
Unknown | 16 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 March 2024.
All research outputs
#1,797,983
of 25,371,288 outputs
Outputs from Reproductive Biology and Endocrinology
#77
of 1,134 outputs
Outputs of similar age
#10,703
of 178,588 outputs
Outputs of similar age from Reproductive Biology and Endocrinology
#2
of 14 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,134 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 178,588 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.